Caprolactam Chemicals Ltd discloses non-applicability of Related Party Transaction regulations for FY26

1 min read     Updated on 22 Apr 2026, 02:59 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Caprolactam Chemicals Ltd informed BSE that it is exempt from Related Party Transaction disclosures under Regulation 23(9) of SEBI LODR Regulations, 2015 for FY26, as its paid-up equity share capital of Rs. 4,60,00,000 and net worth of Rs. 4,95,89,569 as on March 31, 2025, are below the threshold limits of Rs. 10 crore and Rs. 25 crore respectively.

powered bylight_fuzz_icon
38395780

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Ltd has submitted a disclosure to BSE Limited regarding the non-applicability of Regulation 23(9) of the SEBI (LODR) Regulations, 2015, which mandates the disclosure of Related Party Transactions. The communication, dated April 22, 2026, was addressed to the stock exchange from Mumbai.

The company cited Regulation 15(2) of the SEBI (LODR) Regulations, 2015, which exempts listed entities from complying with corporate governance provisions under various regulations, including Regulation 23(9). This exemption applies to companies whose paid-up equity share capital does not exceed rupees ten crore and whose net worth does not exceed rupees twenty-five crore as on the last day of the previous financial year.

Financial Position as on March 31, 2025

Parameter Amount
Paid-up Equity Share Capital Rs. 4,60,00,000
Net Worth Rs. 4,95,89,569

Based on these figures, Caprolactam Chemicals Ltd confirmed that it is not required to submit Related Party Transaction disclosures as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015. The company requested BSE Limited to take this information on record.

The disclosure was signed by the Company Secretary on behalf of Caprolactam Chemicals Limited. The company's BSE code is 507486.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-4.49%+13.47%+11.67%+8.48%+59.81%

Will Caprolactam Chemicals' exemption status affect investor confidence given the reduced transparency requirements?

How might the company's growth plans be impacted by the need to maintain its size below exemption thresholds?

What are the potential risks for minority shareholders when related party transaction disclosures are not mandatory?

like15
dislike

Caprolactam Chemical Limited Announces Unanimous Approval of Postal Ballot Resolutions

1 min read     Updated on 30 Mar 2026, 06:37 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Caprolactam Chemical Limited announced unanimous approval of all four postal ballot resolutions on 30th March, 2026. Each resolution received 82 votes representing 147487 shares with zero opposition votes. The approved measures include special resolutions for remuneration revisions of key executives Mr. Siddharth Shankarlal Bhanushali and Ms. Zaver Shankarlal Bhanushali, plus ordinary resolutions for related party transactions involving property leasing and consultancy fees.

powered bylight_fuzz_icon
36421664

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemical Limited has successfully concluded its postal ballot process with unanimous shareholder approval across all proposed resolutions. The company announced the results on 30th March, 2026, following the scrutinizer's report submission.

Postal Ballot Overview

The postal ballot process was initiated through a notice dated 25th February, 2026, with voting conducted from 28th February, 2026 at 10:00 a.m. (IST) to 29th March, 2026 at 5:00 p.m. (IST). Mr. Rahul Shivji Gori served as the appointed scrutinizer for the entire process.

Resolutions and Voting Results

All four resolutions received identical voting support, demonstrating strong shareholder confidence in the company's proposals:

Resolution Details: Type Votes in Favor Votes Against
Remuneration revision for Mr. Siddharth Shankarlal Bhanushali (CFO cum Whole-Time Director) Special Resolution 82 votes (147487 shares) 0
Remuneration revision for Ms. Zaver Shankarlal Bhanushali (Managing Director) Special Resolution 82 votes (147487 shares) 0
Related party transaction with Ms. Shital Bhanushali for property leasing Ordinary Resolution 82 votes (147487 shares) 0
Consultancy fees revision for Mr. Shankar Bhanushali Ordinary Resolution 82 votes (147487 shares) 0

Detailed Voting Analysis

The voting pattern revealed that participation came exclusively from the Public-Non Institutions category, which holds 2092947 shares out of the company's total 4600000 shares. The 147487 shares voted represented 7.0469% of the outstanding shares in this category.

Key Resolution Details

The approved resolutions encompass critical governance and operational matters:

  • Executive Remuneration: Both special resolutions address compensation adjustments for senior leadership, including the Chief Financial Officer cum Whole-Time Director and Managing Director
  • Related Party Transactions: The ordinary resolutions cover property leasing arrangements and consultancy fee structures with related parties
  • Promoter Interest: All resolutions involved promoter group interests, as disclosed in the voting documentation

Corporate Governance Compliance

The postal ballot results were announced in accordance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company maintained full transparency throughout the process, with detailed voting breakdowns provided for each shareholder category including Promoter and Promoter Group, Public Institutions, and Public-Non Institutions.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.00%-4.49%+13.47%+11.67%+8.48%+59.81%

How will the approved remuneration revisions impact Caprolactam Chemical Limited's operational costs and profit margins in the upcoming fiscal year?

What strategic initiatives might the company pursue with the newly approved related party transactions and consultancy arrangements?

Could the unanimous shareholder approval signal potential major corporate restructuring or expansion plans in the pipeline?

like17
dislike

More News on Caprolactam Chemicals

1 Year Returns:+8.48%